Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models-Reference-Cited by-同舟云学术

Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models

Published:2021-12-02 Issue:10-12 Volume:22 Page:619-629
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Crawford Kate¹,Bontrager Erin¹,Schwarz Margaret A.²³,Chaturvedi Apurva¹,Lee Daniel D.²,Md Sazzad Hassan¹³,von Holzen Urs⁴,Zhang Changhua⁵,Schwarz Roderich E.⁴⁶,Awasthi Niranjan¹³^ORCID

Affiliation:

1. Department of Surgery, Indiana University School of Medicine, South Bend, IN, USA

2. Department of Pediatrics, Indiana University School of Medicine, South Bend, IN, USA

3. Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN, USA

4. University at Buffalo, Buffalo, Ny, USA

5. Department of Gastrointestinal Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China

6. Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Funder

Indiana University School of Medicine

School of Medicine, Indiana University

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2021.2011642

Reference58 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis

3. Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial

4. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer

5. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Multi-omics analysis of programmed cell death-mediated tumor microenvironment heterogeneity;Frontiers in Oncology;2024-03-26

2. Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway;Biomedicines;2023-11-27

3. Enhanced Antitumor Effects of Thymoquinone in Combination with Paclitaxel on Hepatocellular Carcinoma Cell Lines: Role of P53 Modulation;2023-10-12

4. FGFR families: biological functions and therapeutic interventions in tumors;MedComm;2023-09-23

5. Enhanced Antitumor Effects of Thymoquinone in Combination with Paclitaxel on Hepatocellular Carcinoma Cell Lines: Role of P53 Modulation;2023-08-29